Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tildacerfont

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spruce Biosciences Reports Q2 2024 Results And Corporate Updates
    Spruce Biosciences Reports Q2 2024 Results And Corporate Updates

    12 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240812918390/en

    BUSINESSWIRE
    12 Aug 2024
    Share Share
    Spruce's Tildacerfont PCOS Phase 2 POWER Results At ENDO 2024
    Spruce's Tildacerfont PCOS Phase 2 POWER Results At ENDO 2024

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603519582/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share
    Spruce and Kaken Announce Partnership to DevelopTildacerfont for CAH in Japan
    Spruce and Kaken Announce Partnership to DevelopTildacerfont for CAH in Japan

    05 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230105005941/en

    BUSINESSWIRE
    05 Jan 2023
    Share Share
    Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
    Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022

    24 Jan 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220124005159/en

    BUSINESSWIRE
    24 Jan 2022
    Share Share
    Spruce Biosciences to Announce Phase 1 and 2 Data of Tildacerfont
    Spruce Biosciences to Announce Phase 1 and 2 Data of Tildacerfont

    02 Mar 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/spruce-biosciences-to-announce-phase-1-and-2-data-of-tildacerfont-at-endocrine-society-s-2021-annual-meeting/#:~:text=(Nasdaq%3A%20SPRB)%2C%20a,adrenal%20hyperplasia%20will%20be%20shared

    BIOSPACE
    02 Mar 2021
    Share Share